Lupin Limited announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA)...
Lupin Limited has secured U.S. FDA approval for Ranluspec™ (ranibizumab-hkdz), an interchangeable biosimilar to Genentech’s Lucentis® — a milestone that reshapes patient access to sight-saving biologics across...
Diabetic Care Revolution: Lupin Launches Emergency Kit
PharmaGenDRx News Bureau-12th August,2025
Global pharmaceutical leader Lupin limited has announced the launch of Glucagon for Injection USP, 1mg/vial...